13F HOLDINGS REPORT
CHI Advisors LLC
Quarter ended Q2 2023 · Filed May 11, 2023 · Accession 0001085146-23-002240
Total Value
$376.7M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 934,135 | $100.3M | 26.61% |
| 2 | PLIANT THERAPEUTICS INC | PLRX | 3,001,835 | $79.8M | 21.20% |
| 3 | VECTIVBIO HLDG AG | H9060V101 | 5,255,484 | $44.7M | 11.87% |
| 4 | CULLINAN ONCOLOGY INC | CGEM | 3,349,460 | $34.3M | 9.10% |
| 5 | REPARE THERAPEUTICS INC | 760273102 | 2,997,939 | $29.5M | 7.83% |
| 6 | LARIMAR THERAPEUTICS INC | LRMR | 2,746,265 | $12.4M | 3.30% |
| 7 | KEROS THERAPEUTICS INC | KROS | 261,059 | $11.1M | 2.96% |
| 8 | COMPASS THERAPEUTICS INC | CMPX | 2,829,712 | $9.3M | 2.46% |
| 9 | 2SEVENTY BIO INC | 901384107 | 855,000 | $8.7M | 2.32% |
| 10 | INOZYME PHARMA INC | 45790W108 | 1,342,191 | $7.7M | 2.04% |
| 11 | OMEGA THERAPEUTICS INC | 68217N105 | 1,055,882 | $6.4M | 1.69% |
| 12 | IKENA ONCOLOGY INC | 45175G108 | 1,660,872 | $5.7M | 1.52% |
| 13 | RALLYBIO CORP | RLYB | 760,543 | $4.3M | 1.15% |
| 14 | ORCHARD THERAPEUTICS PLC | 68570P200 | 785,738 | $4.2M | 1.12% |
| 15 | CHINOOK THERAPEUTICS INC | 16961L106 | 135,000 | $3.1M | 0.83% |
| 16 | PRECISION BIOSCIENCES INC | DTIL | 3,469,820 | $2.6M | 0.69% |
| 17 | OVID THERAPEUTICS INC | OVID | 864,822 | $2.2M | 0.59% |
| 18 | KEZAR LIFE SCIENCES INC | KZR | 689,451 | $2.2M | 0.57% |
| 19 | FREELINE THERAPEUTICS HLDGS | 35655L107 | 4,729,419 | $2.2M | 0.57% |
| 20 | CORVUS PHARMACEUTICALS INC | CRVS | 2,339,402 | $2.1M | 0.57% |
| 21 | SYROS PHARMACEUTICALS INC | 87184Q206 | 767,445 | $2.0M | 0.54% |
| 22 | ENTRADA THERAPEUTICS INC | TRDA | 56,374 | $817,423 | 0.22% |
| 23 | ONCORUS INC | 68236R103 | 2,367,436 | $814,634 | 0.22% |
| 24 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 25,000 | $108,125 | 0.03% |